Kither Biotech Raises €18 5 Million Series B and Appoints Dr Vincent Metzler as Chief Executive Officer | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.
Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer Proceeds to support the further development of.
Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ PEP-Therapy, a clinical-stage biotechnology company developing cell penetrating peptides as targeted therapies in oncology, and Institut Curie,.